ADVM Competitors & Alternatives
Compare Adverum Biotechnologies, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
ADVM
Main Stock$4.36
Tradestie Score
53
Market Cap
$105.13M
Revenue Growth
-0.7%
Analyst Upside
+12.4%
Top Competitors
6 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$2.44
|
$552.46M | - | 66 | Compare |
|
RGNX
REGENXBIO Inc.
|
$7.17
|
$493.52M | - | 41 | Compare |
|
VYGR
Voyager Therapeutics, Inc. Common Stock
|
$1.86
|
$259.59M | - | 37 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$20.28
|
$188.81M | 19.7 | 58 | Compare |
|
ATRA
Atara Biotherapeutics, Inc
|
$9.43
|
$101.48M | - | 49 | Compare |
More ADVM Analysis
Data updated: Oct 22, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
6 stocks in this industry